Search

everythinglearnresearchcommunity

for

Search:↓

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Blocking a specific receptor slows down hair loss in mice.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Blocking IL-8 can reduce skin rashes from cancer treatment.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Promising cancer treatments were found, but the manufacturer closed.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.